Northwest Biotherapeutics makes changes to management team
Linda Powers becomes chief executive
Linda Powers, who has been chairman since May 2007, has become chief executive, while Dr Anthony Maida, a senior executive in the field of cancer immune therapies, is joining the company as chief operating officer on 20 June.
Dr Alton Boynton, the scientific founder of NWBT and chief executive since May 2007, is returning to the position of chief scientific officer.
Les Goldman, a former partner at US law firm Skadden, Arps, specialising in advanced technology commercialisation, has been appointed as senior vice president, business development. Dr Marnix Bosch will continue in his role as chief technology officer.
You may also like
Manufacturing
Watson-Marlow introduces DriveSure OEM pump solution at ACHEMA 2024
Visitors to Booth C48 in Hall 3.1 at Messe Frankfurt GmbH will learn how the cool, quiet and compact design with precise performance makes DriveSure suitable for the demands of laboratories, cleanrooms, hospitals and process environments